Prudential Financial’s Lucid Diagnostics LUCD Stock Holding History

Prudential Financial’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.7K	Buy	+11,940	New	+$15.2K	﹤0.01%	2388

Other funds holding LUCD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Prudential Financial's LUCD Position: Q1 2026 in Review

Prudential Financial opened a new position in Lucid Diagnostics (LUCD) in Q1 2026: 11,940 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #2388 among its holdings.

103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

Prudential Financial held 11,940 shares of Lucid Diagnostics worth $13.7K as of Q1 2026.
Lucid Diagnostics was a new Prudential Financial position in Q1 2026.
Lucid Diagnostics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2388 holding.
103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.